SCHEMBL26458404

SCHEMBL26458404

c1ccc(-c2cc(-c3cccc4c3C3(c5ccccc5Oc5ccccc53)c3cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc3-4)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.43
KMT2A Q03164 7/20 0.43
MAPT P10636 6/20 0.43
HPGD P15428 6/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 3/20 0.41
LMNA P02545 3/20 0.41
GLA P06280 1/20 0.41
NTSR1 P30989 1/20 0.40
MAOB P27338 5/20 0.35
MAOA P21397 3/20 0.35
ADORA2A P29274 3/20 0.35
ADORA1 P30542 3/20 0.35
CYP2C19 P33261 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
THRB P10828 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26458402 0.95 MEN1 (0.43) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL26458563 0.95 MEN1 (0.43) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL26458424 0.95 MAPT (0.43) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL26458564 0.93 MEN1 (0.44) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21151226 0.93 MEN1 (0.41) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21151553 0.93 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL23642969 0.92 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL26458600 0.92 MEN1 (0.42) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL26458208 0.92 MEN1 (0.45) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL22216545 0.92 MEN1 (0.36) MEN1KMT2AMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641778-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641778-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, CRY2 MEN1 353/4885KMT2A 1182/4885MAPT 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.